Patients with early stage of cervical cancer when treated with surgery or radiotherapy are likely to have a good analysis. However, besides good analysis treatment failure still occurs and about 30% of the patients treated for cervical carcinoma develop advanced or repeated tumours. Patients who suffer recurrence have a miserable prognosis with a 1-year survival rate of between 15 and 20% Recurrent cervical cancer is defined as local tumour re-growth or the development of nodal or distant metastases at least 6 months after the injury has relapsed. Outstanding disease is that which is evident within 6 months of primary treatment. Risk factors for recurrence of cervical carcinoma include the histological type, size, depth of stromal invasion, and the nodal status at presentation.